title: Noninvasive vs conventional mechanical ventilation in acute respiratory failure: a multicenter, randomized controlled trial.
abstract: OBJECTIVE
  Noninvasive mechanical ventilation (NIMV) is beneficial for patients with acute respiratory failure (ARF) when added to medical treatment. However, its role as an alternative to conventional mechanical ventilation (CMV) remains controversial. Our aim was to compare the efficacy and resource consumption of NIMV against CMV in patients with ARF.
  
  
  METHODS
  A randomized, multicenter, controlled trial.
  
  
  METHODS
  Seven multipurpose ICUs.
  
  
  METHODS
  Sixty-four patients with ARF from various causes who fulfilled criteria for mechanical ventilation.
  
  
  METHODS
  The noninvasive group received ventilation through a face mask in pressure-support mode plus positive end-expiratory pressure; the conventional group received ventilation through a tracheal tube.
  
  
  RESULTS
  Avoidance of intubation, mortality, and consumption of resources were the outcome variables. Thirty-one patients were assigned to the noninvasive group, and 33 were assigned to the conventional group. In the noninvasive group, 58% patients were intubated, vs 100% in the conventional group (relative risk reduction, 43%; p < 0.001). Stratification by type of ARF gave similar results. In the ICU, death occurred in 23% and 39% (p = 0.09) and complications occurred in 52% and 70% (p = 0.07) in the noninvasive and conventional groups, respectively. There were no differences in length of stay. The Therapeutic Intervention Score System-28, but not the direct nursing activity time, was lower in the noninvasive group during the first 3 days.
  
  
  CONCLUSIONS
  NIMV reduces the need for intubation and therapeutic intervention in patients with ARF from different causes. There is a nonsignificant trend of reduction in ICUs and hospital mortality together with fewer complications during ICU stay.
authors.affiliation: Unidad de Epidemiología Clínica, Hospital Universitario Puerta de Hierro, San Martín de Porres, 4, 28035 Madrid, Spain.
authors.forename: Teresa
authors.initials: T
authors.lastname: Honrubia
authors.forename: Fernando J
authors.initials: FJ
authors.lastname: García López
authors.forename: Nieves
authors.initials: N
authors.lastname: Franco
authors.forename: Margarita
authors.initials: M
authors.lastname: Mas
authors.forename: Marcela
authors.initials: M
authors.lastname: Guevara
authors.forename: Martín
authors.initials: M
authors.lastname: Daguerre
authors.forename: Inmaculada
authors.initials: I
authors.lastname: Alía
authors.forename: Alejandro
authors.initials: A
authors.lastname: Algora
authors.forename: Pedro
authors.initials: P
authors.lastname: Galdos
mesh_terms: D018806:APACHE; D000208:Acute Disease; D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D003422:Critical Care / Q000379:methods; D016638:Critical Illness; D005260:Female; D006801:Humans; D007362:Intensive Care Units; D007442:Intubation, Intratracheal / Q000009:adverse effects / Q000379:methods*; D017214:Laryngeal Masks; D008297:Male; D008875:Middle Aged; D010102:Oxygen Inhalation Therapy / Q000009:adverse effects / Q000379:methods*; D011175:Positive-Pressure Respiration / Q000009:adverse effects / Q000379:methods; D011336:Probability; D011379:Prognosis; D012121:Respiration, Artificial / Q000009:adverse effects / Q000379:methods*; D012131:Respiratory Insufficiency / Q000175:diagnosis / Q000401:mortality* / Q000628:therapy*; D018570:Risk Assessment; D018709:Statistics, Nonparametric; D015996:Survival Rate; D016896:Treatment Outcome